INDV
Price
$10.76
Change
+$1.31 (+13.86%)
Updated
Apr 24 closing price
Capitalization
2.91B
90 days until earnings call
TEVA
Price
$14.72
Change
+$0.43 (+3.01%)
Updated
Apr 24 closing price
Capitalization
15.06B
12 days until earnings call
Ad is loading...

INDV vs TEVA

Header iconINDV vs TEVA Comparison
Open Charts INDV vs TEVABanner chart's image
Indivior
Price$10.76
Change+$1.31 (+13.86%)
Volume$1.32M
Capitalization2.91B
Teva Pharmaceutical Industries
Price$14.72
Change+$0.43 (+3.01%)
Volume$8.36M
Capitalization15.06B
INDV vs TEVA Comparison Chart
Loading...
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TEVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INDV vs. TEVA commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INDV is a StrongBuy and TEVA is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (INDV: $10.76 vs. TEVA: $14.72)
Brand notoriety: INDV: Not notable vs. TEVA: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: INDV: 92% vs. TEVA: 69%
Market capitalization -- INDV: $2.91B vs. TEVA: $15.06B
INDV [@Pharmaceuticals: Other] is valued at $2.91B. TEVA’s [@Pharmaceuticals: Other] market capitalization is $15.06B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INDV’s FA Score shows that 0 FA rating(s) are green whileTEVA’s FA Score has 1 green FA rating(s).

  • INDV’s FA Score: 0 green, 5 red.
  • TEVA’s FA Score: 1 green, 4 red.
According to our system of comparison, TEVA is a better buy in the long-term than INDV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INDV’s TA Score shows that 5 TA indicator(s) are bullish while TEVA’s TA Score has 4 bullish TA indicator(s).

  • INDV’s TA Score: 5 bullish, 3 bearish.
  • TEVA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, INDV is a better buy in the short-term than TEVA.

Price Growth

INDV (@Pharmaceuticals: Other) experienced а +19.42% price change this week, while TEVA (@Pharmaceuticals: Other) price change was +7.84% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +4.30%. For the same industry, the average monthly price growth was -2.30%, and the average quarterly price growth was -8.27%.

Reported Earning Dates

INDV is expected to report earnings on Jul 24, 2025.

TEVA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+4.30% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TEVA($15.1B) has a higher market cap than INDV($2.91B). INDV has higher P/E ratio than TEVA: INDV (2102.00) vs TEVA (22.62). INDV YTD gains are higher at: -13.435 vs. TEVA (-33.212). TEVA has higher annual earnings (EBITDA): 1.56B vs. INDV (66M). TEVA has more cash in the bank: 3.23B vs. INDV (410M). INDV has less debt than TEVA: INDV (282M) vs TEVA (20.2B). TEVA has higher revenues than INDV: TEVA (15.8B) vs INDV (1.09B).
INDVTEVAINDV / TEVA
Capitalization2.91B15.1B19%
EBITDA66M1.56B4%
Gain YTD-13.435-33.21240%
P/E Ratio2102.0022.629,291%
Revenue1.09B15.8B7%
Total Cash410M3.23B13%
Total Debt282M20.2B1%
FUNDAMENTALS RATINGS
INDV vs TEVA: Fundamental Ratings
INDV
TEVA
OUTLOOK RATING
1..100
7122
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
72
Overvalued
PROFIT vs RISK RATING
1..100
6452
SMR RATING
1..100
6193
PRICE GROWTH RATING
1..100
6364
P/E GROWTH RATING
1..100
9811
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TEVA's Valuation (72) in the Pharmaceuticals Generic industry is in the same range as INDV (100) in the null industry. This means that TEVA’s stock grew similarly to INDV’s over the last 12 months.

TEVA's Profit vs Risk Rating (52) in the Pharmaceuticals Generic industry is in the same range as INDV (64) in the null industry. This means that TEVA’s stock grew similarly to INDV’s over the last 12 months.

INDV's SMR Rating (61) in the null industry is in the same range as TEVA (93) in the Pharmaceuticals Generic industry. This means that INDV’s stock grew similarly to TEVA’s over the last 12 months.

INDV's Price Growth Rating (63) in the null industry is in the same range as TEVA (64) in the Pharmaceuticals Generic industry. This means that INDV’s stock grew similarly to TEVA’s over the last 12 months.

TEVA's P/E Growth Rating (11) in the Pharmaceuticals Generic industry is significantly better than the same rating for INDV (98) in the null industry. This means that TEVA’s stock grew significantly faster than INDV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INDVTEVA
RSI
ODDS (%)
Bearish Trend 1 day ago
60%
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
73%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
72%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
67%
Advances
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
71%
Declines
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 21 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
68%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
62%
View a ticker or compare two or three
Ad is loading...
INDV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TEVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RERCX54.010.63
+1.18%
American Funds Europacific Growth R3
RRRCX21.46N/A
N/A
DWS RREEF Real Estate Securities C
LICVX15.89N/A
N/A
Lord Abbett International Equity R6
MGHRX51.91N/A
N/A
Morgan Stanley Inst Growth IR
IEYAX8.35N/A
N/A
Macquarie Climate Solutions A

INDV and

Correlation & Price change

A.I.dvisor tells us that INDV and CAIHF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INDV and CAIHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDV
1D Price
Change %
INDV100%
+13.86%
CAIHF - INDV
27%
Poorly correlated
N/A
ASRT - INDV
26%
Poorly correlated
+4.20%
MKKGY - INDV
24%
Poorly correlated
+1.64%
TEVA - INDV
22%
Poorly correlated
+3.01%
PAHC - INDV
22%
Poorly correlated
+4.77%
More